⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918471 | 1.00 | — | — | |
| SCHEMBL1288233 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL349149 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2029151 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28273537 | 0.97 | CA1 (0.43) | — | |
| SCHEMBL18833452 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1064128 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28666579 | 0.97 | CA1 (0.43) | — | |
| Water SCHEMBL28662108 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28273538 | 0.97 | CA1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114634437-B | Simple preparation method of brivaracetam | 武汉氟本氘合新材料科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-112195203-B | Method for synthesizing (S) -2-aminobutanamide by enzyme method | 江苏八巨药业有限公司 | 2022-07-26 | — | — | CN | claimed |
| CN-114634437-A | Simple preparation method of brivaracetam | 武汉氟本氘合新材料科技有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-112195203-A | Method for synthesizing (S) -2-aminobutanamide by enzyme method | 江苏八巨药业有限公司 | 2021-01-08 | — | — | CN | claimed |
| CN-109134341-A | A kind of preparation method of Levetiracetam | 黑龙江珍宝岛药业股份有限公司 | 2019-01-04 | — | — | CN | claimed |
| JP-4511835-B2 | — | — | 2010-07-28 | — | — | JP | claimed |
| EP-1442050-A2 | LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF | MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) | 2004-08-04 | — | — | EP | claimed |
| WO-2003037916-A2 | LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF | MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. (IT) | 2003-05-08 | — | — | WO | claimed |
| US-20260008787-A1 | FUSED RING KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS INC (US) | 2026-01-08 | — | — | US | disclosed |
| EP-4021901-B1 | SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-4551577-A1 | FUSED RING KRAS INHIBITORS FOR TREATING DISEASE | Blossomhill Therapeutics, Inc. (US) | 2025-05-14 | — | — | EP | disclosed |
| CN-119790058-A | Fused cyclic KRAS inhibitors for the treatment of diseases | 荣山医药股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240400563-A1 | SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL-MYERS SQUIBB COMPANY | 2024-12-05 | — | — | US | disclosed |
| WO-2024151638-A2 | COMPOUNDS FOR FGFRS INHIBITORS | COGENT BIOSCIENCES, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20070015774-A1 | Quinazoline derivatives useful in cancer treatment | SCHERING CORPORATION | 2007-01-18 | — | — | US | disclosed |
| WO-2006095362-A1 | PROCESS FOR PREPARING LEVETIRACETAM | RUBAMIN LIMITED (IN) | 2006-09-14 | — | — | WO | disclosed |
| US-20050059827-A1 | Process for the preparation of valsartan and intermediates thereof | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2005-03-17 | — | — | US | disclosed |
| US-20050059827-A1 | Process for the preparation of valsartan and intermediates thereof | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2005-03-17 | — | — | US | disclosed |
| WO-2004101534-A1 | A METHOD OF PREPARATION OF N-(1-OXOPENTYL)-N-[[2'-(1H-TETRAZOL-5-y1) [1,1'-BIPHENYL] -4-y1]METHYL]-L-VALINE (VALSARTAN) | ZENTIVA, A. S. (CZ) | 2004-11-25 | — | — | WO | disclosed |
| CN-1376143-A | Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient | TORAY INDUSTRIES (JP) | 2002-10-23 | — | — | CN | disclosed |